Terms: = Lung cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Treatment
253 results:
1. Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells.
Salerno L; Notaro A; Consoli V; Affranchi F; Pittalà V; Sorrenti V; Vanella L; Giuliano M; Intagliata S
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2337191. PubMed ID: 38634597
[TBL] [Abstract] [Full Text] [Related]
2. Redox
Wei XW; Lu C; Zhang YC; Fan X; Xu CR; Chen ZH; Wang F; Yang XR; Deng JY; Yang MY; Gou Q; Mei SQ; Luo WC; Zhong RW; Zhong WZ; Yang JJ; Zhang XC; Tu HY; Wu YL; Zhou Q
Oncoimmunology; 2024; 13(1):2340154. PubMed ID: 38601319
[TBL] [Abstract] [Full Text] [Related]
3. Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in
Pillai R; LeBoeuf SE; Hao Y; New C; Blum JLE; Rashidfarrokhi A; Huang SM; Bahamon C; Wu WL; Karadal-Ferrena B; Herrera A; Ivanova E; Cross M; Bossowski JP; Ding H; Hayashi M; Rajalingam S; Karakousi T; Sayin VI; Khanna KM; Wong KK; Wild R; Tsirigos A; Poirier JT; Rudin CM; Davidson SM; Koralov SB; Papagiannakopoulos T
Sci Adv; 2024 Mar; 10(13):eadm9859. PubMed ID: 38536921
[TBL] [Abstract] [Full Text] [Related]
4. YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.
Kook E; Lee J; Kim DH
Arch Toxicol; 2024 May; 98(5):1437-1455. PubMed ID: 38443724
[TBL] [Abstract] [Full Text] [Related]
5. SLC15A3 plays a crucial role in pulmonary fibrosis by regulating macrophage oxidative stress.
Luo J; Li P; Dong M; Zhang Y; Lu S; Chen M; Zhou H; Lin N; Jiang H; Wang Y
Cell Death Differ; 2024 Apr; 31(4):417-430. PubMed ID: 38374230
[TBL] [Abstract] [Full Text] [Related]
6. Cephaeline promotes ferroptosis by targeting nrf2 to exert anti-lung cancer efficacy.
Chen P; Ye Q; Liang S; Zeng L
Pharm Biol; 2024 Dec; 62(1):195-206. PubMed ID: 38339810
[TBL] [Abstract] [Full Text] [Related]
7. Glutathione Depletion-Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy.
Song H; Sun H; He N; Xu C; Du L; Ji K; Wang J; Zhang M; Gu Y; Wang Y; Liu Q
Adv Healthc Mater; 2024 Apr; 13(9):e2303412. PubMed ID: 38245863
[TBL] [Abstract] [Full Text] [Related]
8. PSMD12 promotes non-small cell lung cancer progression through activating the nrf2/TrxR1 pathway.
Lv J; Ma S; Wang X; Dang J; Ma F
Genes Genomics; 2024 Mar; 46(3):263-277. PubMed ID: 38243044
[TBL] [Abstract] [Full Text] [Related]
9. APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by nrf2/HO-1.
Mei L; Long J; Wu S; Mei M; Mei D; Qiu H
Anticancer Drugs; 2024 Apr; 35(4):333-343. PubMed ID: 38241194
[TBL] [Abstract] [Full Text] [Related]
10. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/nrf2 signaling pathway.
Chen L; Yu W; Tang H; Zhang S; Wang J; Ouyang Q; Guo M; Zhu X; Huang Z; Chen J
Metallomics; 2024 Jan; 16(1):. PubMed ID: 38183290
[TBL] [Abstract] [Full Text] [Related]
11. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
12. Acrolein suppresses anticancer drug-induced toxicity mediated by activating claudin-1 and nrf2 axis in a spheroid model of human lung squamous cell carcinoma cells.
Eguchi H; Yu Y; Matsunaga T; Yoshino Y; Ikari A
Toxicol Lett; 2024 Feb; 392():46-55. PubMed ID: 38142011
[TBL] [Abstract] [Full Text] [Related]
13. [Research Progress of nrf2 and Ferroptosis in Tumor Drug Resistance].
Hu S; Zou X; Fang Y; Liu C; Chen R; Ji L
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):765-773. PubMed ID: 37989339
[TBL] [Abstract] [Full Text] [Related]
14. Prostaglandin 15d-PGJ
Slanovc J; Mikulčić M; Jahn N; Wizsy NGT; Sattler W; Malle E; Hrzenjak A
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166924. PubMed ID: 37898426
[TBL] [Abstract] [Full Text] [Related]
15. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance.
Zavitsanou AM; Pillai R; Hao Y; Wu WL; Bartnicki E; Karakousi T; Rajalingam S; Herrera A; Karatza A; Rashidfarrokhi A; Solis S; Ciampricotti M; Yeaton AH; Ivanova E; Wohlhieter CA; Buus TB; Hayashi M; Karadal-Ferrena B; Pass HI; Poirier JT; Rudin CM; Wong KK; Moreira AL; Khanna KM; Tsirigos A; Papagiannakopoulos T; Koralov SB
Cell Rep; 2023 Nov; 42(11):113295. PubMed ID: 37889752
[TBL] [Abstract] [Full Text] [Related]
16. Combination of ferroptosis and pyroptosis dual induction by triptolide nano-MOFs for immunotherapy of Melanoma.
Wang S; Guo Q; Xu R; Lin P; Deng G; Xia X
J Nanobiotechnology; 2023 Oct; 21(1):383. PubMed ID: 37858186
[TBL] [Abstract] [Full Text] [Related]
17. Ginsenosides: a potential natural medicine to protect the lungs from lung cancer and inflammatory lung disease.
Wang L; Zhang Y; Song Z; Liu Q; Fan D; Song X
Food Funct; 2023 Oct; 14(20):9137-9166. PubMed ID: 37801293
[TBL] [Abstract] [Full Text] [Related]
18. Potential Therapeutic Targets of Resveratrol in the Prevention and treatment of Pulmonary Fibrosis.
Ramli I; Cheriet T; Posadino AM; Giordo R; Zayed H; Eid AH; Pintus G
Front Biosci (Landmark Ed); 2023 Sep; 28(9):198. PubMed ID: 37796708
[TBL] [Abstract] [Full Text] [Related]
19. Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis.
Gao M; Lai K; Deng Y; Lu Z; Song C; Wang W; Xu C; Li N; Geng Q
Aging (Albany NY); 2023 Oct; 15(19):10089-10104. PubMed ID: 37787987
[TBL] [Abstract] [Full Text] [Related]
20. Metformin induces ferroptosis through the nrf2/HO-1 signaling in lung cancer.
Deng C; Xiong L; Chen Y; Wu K; Wu J
BMC Pulm Med; 2023 Sep; 23(1):360. PubMed ID: 37749553
[TBL] [Abstract] [Full Text] [Related]
[Next]
